Formenti SC - Search Results

1

Cesium-131 brachytherapy in high risk and recurrent head and neck cancers: first report of long-term outcomes.

Pham A, Arora S, Wernicke AG, Kutler DI, Cohen M, Kuhel W, Trichter S, Nori D, Formenti SC, Parashar B. Pham A, et al. Among authors: formenti sc. J Contemp Brachytherapy. 2015 Dec;7(6):445-52. doi: 10.5114/jcb.2015.56764. Epub 2015 Dec 30. J Contemp Brachytherapy. 2015. PMID: 26816501 Free PMC article.

2

External beam partial-breast radiotherapy: crucial differences between NYU 00-23 and RTOG 0319: in regard to Vicini et al. (Int J Radiat Oncol Biol Phys 2005;63:1531-1537).

Formenti SC, Wernicke AG, DeWyngaert JK. Formenti SC, et al. Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):630; author reply 630-1. doi: 10.1016/j.ijrobp.2006.05.049. Int J Radiat Oncol Biol Phys. 2006. PMID: 16966007 No abstract available.

3

Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique.

Hardee ME, Raza S, Becker SJ, Jozsef G, Lymberis SC, Hochman T, Goldberg JD, DeWyngaert KJ, Formenti SC. Hardee ME, et al. Among authors: formenti sc. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e415-23. doi: 10.1016/j.ijrobp.2011.06.1950. Epub 2011 Oct 20. Int J Radiat Oncol Biol Phys. 2012. PMID: 22019349

4

Prone accelerated partial breast irradiation after breast-conserving surgery: compliance to the dosimetry requirements of RTOG-0413.

Wen B, Hsu H, Formenti-Ujlaki GF, Lymberis S, Magnolfi C, Zhao X, Chang J, DeWyngaert JK, Jozsef G, Formenti SC. Wen B, et al. Among authors: formenti sc, formenti ujlaki gf. Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):910-6. doi: 10.1016/j.ijrobp.2012.01.055. Epub 2012 Apr 28. Int J Radiat Oncol Biol Phys. 2012. PMID: 22543213 Clinical Trial.

5

Hypofractionated radiation therapy for early stage breast cancer: outcomes, toxicities, and cost analysis.

Min C, Connolly E, Chen T, Jozsef G, Formenti SC. Min C, et al. Among authors: formenti sc. Breast J. 2014 May-Jun;20(3):267-73. doi: 10.1111/tbj.12254. Breast J. 2014. PMID: 24750510 Clinical Trial.

6

Breast, chest wall, and nodal irradiation with prone set-up: Results of a hypofractionated trial with a median follow-up of 35 months.

Shin SM, No HS, Vega RM, Fenton-Kerimian M, Maisonet O, Hitchen C, Keith DeWyngaert J, Formenti SC. Shin SM, et al. Among authors: formenti sc. Pract Radiat Oncol. 2016 Jul-Aug;6(4):e81-e88. doi: 10.1016/j.prro.2015.10.022. Epub 2015 Nov 9. Pract Radiat Oncol. 2016. PMID: 26723552

7

Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure.

Katz A, Formenti SC, Kang J. Katz A, et al. Among authors: formenti sc. Front Oncol. 2016 Jul 8;6:168. doi: 10.3389/fonc.2016.00168. eCollection 2016. Front Oncol. 2016. PMID: 27458572 Free PMC article.

8

Results of a phase I-II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer.

Formenti SC, Golden EB, Goldberg JD, Li X, Taff J, Fenton-Kerimian MB, Chandrasekhar S, Demaria S, Novik Y. Formenti SC, et al. Oncoimmunology. 2016 Dec 27;6(3):e1274479. doi: 10.1080/2162402X.2016.1274479. eCollection 2017. Oncoimmunology. 2016. PMID: 28405497 Free PMC article.

9

Development of a Model to Estimate the Association Between Delay in Cancer Treatment and Local Tumor Control and Risk of Metastases.

Ng J, Stovezky YR, Brenner DJ, Formenti SC, Shuryak I. Ng J, et al. Among authors: formenti sc. JAMA Netw Open. 2021 Jan 4;4(1):e2034065. doi: 10.1001/jamanetworkopen.2020.34065. JAMA Netw Open. 2021. PMID: 33502482 Free PMC article.

10

Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial.

Altorki NK, McGraw TE, Borczuk AC, Saxena A, Port JL, Stiles BM, Lee BE, Sanfilippo NJ, Scheff RJ, Pua BB, Gruden JF, Christos PJ, Spinelli C, Gakuria J, Uppal M, Binder B, Elemento O, Ballman KV, Formenti SC. Altorki NK, et al. Among authors: formenti sc. Lancet Oncol. 2021 Jun;22(6):824-835. doi: 10.1016/S1470-2045(21)00149-2. Epub 2021 May 18. Lancet Oncol. 2021. PMID: 34015311 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

275 results

Search Page